Cite
HARVARD Citation
Danese, S. et al. (n.d.). S755 Early Symptom Control With Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis in the LUCENT-1 Induction Trial. American journal of gastroenterology. p. e535. [Online].